Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 540.28B, Johnson & Johnson(JNJ) trades at $224.31. The stock has a price-to-earnings ratio of 26.67 and currently yields dividends of 2.3%.
On 2026-04-22, Johnson & Johnson(JNJ) stock traded between a low of $224.06 and a high of $227.48. Shares are currently priced at $224.31, which is +0.1% above the low and -1.4% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 3.29M, against a daily average of 8.39M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.
JNJ News
Johnson & Johnson announced new data from the Phase 3 Vivacity-MG3 study and ongoing open label extension, or OLE, in a broad population of antibody-positive, o...
Johnson & Johnson JNJ, via its Innovative Medicine segment, markets a broad portfolio of blockbuster therapies across key areas including neuroscience, cardiova...
Piper Sandler raised the firm’s price target on MeiraGTx (MGTX) to $30 from $26 and keeps an Overweight rating on the shares following the company’s long-term d...
Analyst ratings
59%
of 29 ratingsMore JNJ News
Johnson & Johnson (JNJ) stock is drawing attention after recent trading left shares around $226.16, with a 1 day return of about a 2% decline and a past week mo...
GDV’s 6.1% Yield Faces a Hidden Test in 2026 Small-Cap Downturn By David Beren Published Apr 21, 3:34PM EDT Quick Read Gabelli Dividend & Income Trust (GDV) t...
Image source: The Motley Fool. Wednesday, July 30, 2025 at 8:30 a.m. ET Call participants President and Chief Executive Officer — Cheryl Renee Blanchard, Ph.D....
Johnson & Johnson will showcase the latest advances across its electrophysiology portfolio at the 2026 Heart Rhythm Society Annual Meeting, including new eviden...
Biotechs working on psychedelic-based treatments have long been a staple in retail investors portfolios. Now, several are poised to gain federal approval, poten...
Put $5,000 In These Dividend Giants and Earn Passive Income Every Quarter By Vandita Jadeja Published Apr 20, 12:35PM EDT Quick Read Johnson & Johnson (JNJ),...
Technology Eli Lilly Snags $7 Billion Cancer Deal To Rival Gilead, J&J, Others Licensing Eli Lilly (LLY) said Monday it will spend up to $7 billion to buy priva...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.